Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, rates of bariatric surgeries dropped by 25%, while prescriptions for weight-loss drugs more than doubled.

A new, better Ozempic? Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie burning — without any signs of nausea. “While GLP-1-based therapies have revolutionized patient care for obesity and Type 2 diabetes,

"For healthcare providers, these findings suggest that anti-obesity medications may offer dual benefits," one doctor reports of the research.

Medically reviewed by Danielle Weiss, MD After losing extra pounds on Ozempic (semaglutide), some are finding themselves dealing with an unexpected issue, what's become known as "Ozempic breasts." This possible side effect of glucagon-like peptide 1 (GLP-1) agonist medication users like Ozempic,